Stock listing
Lang & Schwarz:A0Q2S4 Codexis, Inc. Aktie
German listing (Lang & Schwarz) of Codexis, Inc. · home listing NASDAQ:CDXS
Follow Codexis, Inc. into a list and get an email when it puts out news.
Home listing price · NASDAQ:CDXS
$1.01 USD -0.14 (-12.2%)
Close on Nov 20, 2026 · This listing has no price on 6ix; the price shown is the home listing's, NASDAQ:CDXS
- Day range
- $0.98 – $1.06 USDNov 20, 2026
- Volume
- 2.07M sharesNov 20, 2026
- Market cap
- $110.7M USDAt the close on Nov 20, 2026 · price × 109.6M shares outstanding
- 52-week range
- $0.90 – $2.98 USDLowest and highest trades, Nov 21, 2025 – Nov 20, 2026
- Traded on an average day
- $1.22M USDMedian day 863,600 shares · last 3 months, Aug 20, 2026 – Nov 20, 2026

Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| NASDAQ:CDXS · Home | $1.01 USD | -0.14 (-12.2%) | 2,067,370 | $1.06 | $1.06 | $0.98 | $1.15 | Close on Nov 20, 2026 |
| LSE:0I0X | $0.987 USD | -0.073 (-6.9%) | 7,772 | $1.190 | $1.190 | $0.979 | $1.060 | Close on Nov 20, 2026 |
| Frankfurt:4QK | €0.897 EUR | -0.040 (-4.3%) | — | €0.937 | €0.937 | €0.884 | €0.938 | Close on Nov 20, 2026 |
Daily closes
Last 3 months, Aug 20, 2026 – Nov 20, 2026 · NASDAQ:CDXS · USD, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| $1.01 | -0.14 | -12.2% | $1.06 | $1.06 | $0.98 | 2,067,370 | |
| $1.15 | +0.08 | +7.5% | $1.07 | $1.18 | $1.06 | 1,465,675 | |
| $1.07 | +0.01 | +0.9% | $1.07 | $1.12 | $1.04 | 1,140,472 | |
| $1.06 | -0.10 | -8.6% | $1.13 | $1.16 | $1.04 | 1,029,476 | |
| $1.16 | +0.202 | +21.1% | $1.13 | $1.20 | $1.04 | 2,498,148 | |
| $0.958 | -0.018 | -1.9% | $0.96 | $0.969 | $0.90 | 1,005,243 | |
| $0.976 | -0.024 | -2.4% | $1.00 | $1.015 | $0.95 | 1,667,437 | |
| $1.00 | -0.11 | -9.9% | $1.12 | $1.145 | $1.00 | 635,243 | |
| $1.11 | +0.03 | +2.8% | $1.11 | $1.17 | $1.08 | 792,941 | |
| $1.08 | +0.06 | +5.9% | $1.03 | $1.10 | $1.025 | 398,250 | |
| $1.02 | -0.06 | -5.6% | $1.09 | $1.10 | $0.992 | 871,747 | |
| $1.08 | 0.00 | 0.0% | $1.11 | $1.13 | $1.07 | 658,193 | |
| $1.08 | +0.035 | +3.3% | $1.04 | $1.08 | $1.04 | 612,927 | |
| $1.045 | -0.145 | -12.2% | $1.20 | $1.22 | $1.04 | 1,128,708 | |
| $1.19 | -0.03 | -2.5% | $1.20 | $1.24 | $1.17 | 789,458 | |
| $1.22 | -0.04 | -3.2% | $1.27 | $1.296 | $1.20 | 915,650 | |
| $1.26 | -0.02 | -1.6% | $1.28 | $1.33 | $1.25 | 1,645,623 | |
| $1.28 | -0.02 | -1.5% | $1.30 | $1.315 | $1.26 | 691,459 | |
| $1.30 | +0.02 | +1.6% | $1.30 | $1.30 | $1.28 | 392,376 | |
| $1.28 | -0.03 | -2.3% | $1.30 | $1.32 | $1.265 | 546,625 | |
| $1.31 | +0.02 | +1.6% | $1.29 | $1.325 | $1.29 | 501,524 | |
| $1.29 | +0.06 | +4.9% | $1.24 | $1.31 | $1.234 | 1,058,060 | |
| $1.23 | -0.09 | -6.8% | $1.32 | $1.35 | $1.21 | 1,288,951 | |
| $1.32 | +0.08 | +6.5% | $1.25 | $1.36 | $1.225 | 1,160,024 | |
| $1.24 | -0.12 | -8.8% | $1.36 | $1.36 | $1.22 | 980,100 | |
| $1.36 | +0.07 | +5.4% | $1.29 | $1.36 | $1.26 | 681,100 | |
| $1.29 | -0.03 | -2.3% | $1.30 | $1.34 | $1.27 | 931,600 | |
| $1.32 | -0.09 | -6.4% | $1.39 | $1.41 | $1.31 | 820,300 | |
| $1.41 | 0.00 | 0.0% | $1.40 | $1.43 | $1.32 | 1,101,000 | |
| $1.41 | +0.05 | +3.7% | $1.36 | $1.41 | $1.34 | 555,400 | |
| $1.36 | -0.05 | -3.5% | $1.39 | $1.40 | $1.35 | 887,200 | |
| $1.41 | +0.05 | +3.7% | $1.33 | $1.45 | $1.33 | 958,200 | |
| $1.36 | -0.03 | -2.2% | $1.40 | $1.45 | $1.36 | 597,900 | |
| $1.39 | +0.03 | +2.2% | $1.38 | $1.41 | $1.34 | 893,200 | |
| $1.36 | 0.00 | 0.0% | $1.39 | $1.41 | $1.35 | 551,900 | |
| $1.36 | -0.03 | -2.2% | $1.39 | $1.41 | $1.34 | 752,100 | |
| $1.39 | +0.04 | +3.0% | $1.36 | $1.41 | $1.35 | 909,800 | |
| $1.35 | -0.01 | -0.7% | $1.36 | $1.39 | $1.35 | 606,400 | |
| $1.36 | +0.04 | +3.0% | $1.31 | $1.39 | $1.31 | 698,900 | |
| $1.32 | -0.05 | -3.6% | $1.38 | $1.40 | $1.32 | 464,300 | |
| $1.37 | -0.01 | -0.7% | $1.38 | $1.42 | $1.35 | 863,600 | |
| $1.38 | -0.01 | -0.7% | $1.39 | $1.40 | $1.32 | 627,700 | |
| $1.39 | +0.01 | +0.7% | $1.39 | $1.43 | $1.38 | 1,039,800 | |
| $1.38 | +0.02 | +1.5% | $1.38 | $1.43 | $1.36 | 539,700 | |
| $1.36 | +0.04 | +3.0% | $1.32 | $1.40 | $1.31 | 2,875,800 | |
| $1.32 | -0.02 | -1.5% | $1.38 | $1.44 | $1.27 | 1,181,400 | |
| $1.34 | -0.06 | -4.3% | $1.42 | $1.43 | $1.34 | 954,200 | |
| $1.40 | -0.08 | -5.4% | $1.47 | $1.49 | $1.38 | 608,700 | |
| $1.48 | +0.01 | +0.7% | $1.45 | $1.50 | $1.43 | 477,600 | |
| $1.47 | +0.03 | +2.1% | $1.45 | $1.48 | $1.43 | 505,100 | |
| $1.44 | +0.01 | +0.7% | $1.42 | $1.45 | $1.41 | 467,300 | |
| $1.43 | 0.00 | 0.0% | $1.43 | $1.45 | $1.42 | 513,300 | |
| $1.43 | -0.03 | -2.1% | $1.48 | $1.50 | $1.43 | 655,000 | |
| $1.46 | +0.04 | +2.8% | $1.43 | $1.48 | $1.43 | 757,800 | |
| $1.42 | -0.06 | -4.1% | $1.48 | $1.50 | $1.41 | 1,010,700 | |
| $1.48 | -0.03 | -2.0% | $1.52 | $1.59 | $1.47 | 998,000 | |
| $1.51 | -0.19 | -11.2% | $1.67 | $1.70 | $1.50 | 1,065,200 | |
| $1.70 | +0.11 | +6.9% | $1.59 | $1.72 | $1.56 | 1,388,900 | |
| $1.59 | -0.07 | -4.2% | $1.66 | $1.68 | $1.58 | 634,600 | |
| $1.66 | +0.01 | +0.6% | $1.64 | $1.66 | $1.60 | 591,800 | |
| $1.65 | -0.03 | -1.8% | $1.68 | $1.70 | $1.61 | 560,000 | |
| $1.68 | +0.02 | +1.2% | $1.67 | $1.72 | $1.66 | 811,000 | |
| $1.66 | -0.01 | -0.6% | $1.69 | $1.77 | $1.63 | 1,359,800 | |
| $1.67 | +0.09 | +5.7% | $1.60 | $1.70 | $1.58 | 1,258,000 | |
| $1.58 | -0.02 | -1.3% | $1.60 | $1.65 | $1.56 | 1,282,400 |
- Ticker
- Lang & Schwarz:A0Q2S4
- Asset type
- Stock
- Exchange
- Lang & Schwarz
- Currency
- EUR
What changed lately
Latest news release · Nov 19, 2026
Codexis to Participate in Piper Sandler 38th Annual Healthcare Conference
Latest earnings call · Nov 12, 2026
Codexis (NASDAQ:CDXS) Q3 2026 Earnings Call
Replay and transcript
Latest deck · September 2026
Investor Presentation (September 2026)
Investor deck · 29 slides
Latest news
Codexis to Participate in Piper Sandler 38th Annual Healthcare Conference
Nov 19, 2026
Closed $1.01 (-12.2%) on Nov 20, 2026
Codexis Reports Third Quarter 2026 Financial Results and Provides Business Update
Nov 12, 2026
Closed $1.16 (+21.1%) on Nov 13, 2026
Codexis Enters into $60 Million Term Loan Facility with Trinity Capital
Nov 10, 2026
Closed $1.00 (-9.9%) on Nov 10, 2026
Codexis Advances ECO Synthesis Toward Adoption Readiness with Quality at Scale and Expanded siRNA Manufacturing Capabilities
Nov 9, 2026
Closed $1.11 (+2.8%) on Nov 9, 2026
Codexis to Report Third Quarter 2026 Financial Results on November 12
Oct 29, 2026
Closed $1.22 (-3.2%) on Oct 29, 2026
Codexis Enters into an Agreement with Pioneering siRNA Drug Innovator to Leverage the ECO Synthesis Manufacturing Platform to Create Stereo-defined siRNA
Sep 28, 2026
Closed $1.36 (+3.0%) on Sep 28, 2026
Codexis to Participate in Cantor Global Healthcare Conference 2026
Aug 27, 2026
Closed $1.66 (+0.6%) on Aug 27, 2026
Codexis Reports Second Quarter 2026 Financial Results
Aug 11, 2026
Closed $1.60 (+8.1%) on Aug 12, 2026
Codexis Appoints David Butler, PhD, to Strategic Advisory Board
Aug 3, 2026
Closed $1.45 (+3.6%) on Aug 3, 2026
Codexis to Report Second Quarter 2026 Financial Results on August 11
Jul 28, 2026
Closed $1.50 (-3.2%) on Jul 28, 2026
Codexis, Inc. on 6ix
- News releases
- 22 in the last 12 months · 185 in all · newest Nov 19, 2026 · oldest 2019
- Calls
- 24 calls with a replay · 24 with a transcript · latest Nov 12, 2026
- Decks
- 24 decks · latest September 2026
Where Codexis, Inc. is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| NASDAQ:CDXS · Home listing | NASDAQ | United States | USD |
| gettex:4QK | gettex | Germany | EUR |
| LS Exchange:A0Q2S4 | LS Exchange | Germany | EUR |
| Lang & Schwarz:A0Q2S4 · This page | Lang & Schwarz | Germany | EUR |
| LSE:0I0X | LSE | United Kingdom | USD |
| BOATS:CDXS | BOATS | United States | USD |
| Frankfurt:4QK | Frankfurt | Germany | EUR |
| Tradegate:4QK | Tradegate | Germany | EUR |
| BX Swiss:4QK | BX Swiss | Switzerland | CHF |
| Dusseldorf:4QK | Dusseldorf | Germany | EUR |
| Munich:4QK | Munich | Germany | EUR |
| Stuttgart:4QK | Stuttgart | Germany | EUR |
Valuation
Statements: 4 quarters to Sep 30, 2026 · price Nov 20, 2026
- Enterprise value
- $79.31M USD
- P/E
- Loss
- EV/sales
- 0.9×
- EV/EBITDA
- Negative EBITDA
- Price/book
- 2.2×
- Gross margin
- 83.9%
- Operating margin
- −18.3%
- Net margin
- −21.8%
- Debt to equity
- 0.8×
- Beta vs S&P 500
- 1.76
Forecasts
5 strong buy · 1 buy · 2 hold · Analysts' consensus from EODHD, read Nov 14, 2026. Not 6ix's view and not investment advice.
- Price target
- 6.14 USD · Analysts' mean
- EPS, year to Dec 2026
- -0.42 · 2 analysts
- Revenue, year to Dec 2026
- 73.76M · 8 analysts
Team and board
| Officer | Role |
|---|---|
| Alison Moore | President and Chief Executive Officer |
| Georgia Erbez | Chief Financial Officer and Chief Business Officer |
| Amy Westfall | Senior Vice President, Strategy and Program Management |
| Britton Jimenez | Senior Vice President, Sales and Marketing |
| Karen Frechou-Armijo | Senior Vice President, Head of Human Resources |
| Stefan Lutz | Chief Scientific Officer |
Events
Calls
| Call | When | Status |
|---|---|---|
| Codexis (NASDAQ:CDXS) Q3 2026 Earnings Call | Thu, Nov 12, 2026 · 4:30 PM ET | Replay |
| Codexis (NASDAQ:CDXS) Q2 2026 Earnings Call | Tue, Aug 11, 2026 · 4:30 PM ET | Replay |
| Codexis (NASDAQ:CDXS) Q1 2026 Earnings Call | Thu, May 07, 2026 · 4:30 PM ET | Replay |
| Codexis (NASDAQ:CDXS) Q4 2025 Earnings Call | Wed, Mar 11, 2026 · 4:30 PM ET | Replay |
| Codexis (NASDAQ:CDXS) Q3 2025 Earnings Call | Thu, Nov 06, 2025 · 4:30 PM ET | Replay |
| Codexis (NASDAQ:CDXS) Q2 2025 Earnings Call | Wed, Aug 13, 2025 · 4:30 PM ET | Replay |
| Codexis (NASDAQ:CDXS) Q1 2025 Earnings Call | Wed, May 14, 2025 · 4:30 PM ET | Replay |
| Codexis (NASDAQ:CDXS) Q4 2024 Earnings Call | Thu, Feb 27, 2025 · 4:30 PM ET | Replay |
| Codexis (NASDAQ:CDXS) Q3 2024 Earnings Call | Thu, Oct 31, 2024 · 4:30 PM ET | Replay |
| Codexis (NASDAQ:CDXS) Q2 2024 Earnings Call | Thu, Aug 08, 2024 · 4:30 PM ET | Replay |
All 24 calls
Results days
| Quarter | Results | Share move |
|---|---|---|
| Q3 2026 | Nov 12, 2026 · After close | +21.1% |
| Q2 2026 | Aug 11, 2026 · After close | +8.1% |
| Q1 2026 | May 7, 2026 · After close | +10.5% |
| Q4 2025 | Feb 26, 2026 | −9.8% |
| Q3 2025 | Nov 6, 2025 · After close | −16.9% |
| Q2 2025 | Aug 13, 2025 · After close | +1.6% |
| Q1 2025 | May 14, 2025 · After close | +1.6% |
| Q4 2024 | Feb 26, 2025 · After close | −5.5% |
| Q3 2024 | Oct 31, 2024 · After close | +11.5% |
| Q2 2024 | Aug 8, 2024 · After close | −11.1% |
All 20 quarters
| Quarter | Results | Share move |
|---|---|---|
| Q1 2024 | May 2, 2024 · After close | +17.4% |
| Q4 2023 | Feb 28, 2024 · After close | +25.0% |
| Q3 2023 | Nov 2, 2023 · After close | +7.2% |
| Q2 2023 | Aug 3, 2023 · After close | −14.5% |
| Q1 2023 | May 4, 2023 · After close | −4.8% |
| Q4 2022 | Feb 23, 2023 · After close | −13.8% |
| Q3 2022 | Nov 3, 2022 · After close | +11.0% |
| Q2 2022 | Aug 4, 2022 · After close | +9.7% |
| Q1 2022 | May 5, 2022 · After close | −0.9% |
| Q4 2021 | Feb 24, 2022 · After close | +3.5% |
Decks
| Deck | Kind | Slides | Date |
|---|---|---|---|
| Investor Presentation (September 2026) | Investor deck | 29 slides | September 2026 |
| Q2 2026 Earnings Presentation | Earnings | 29 slides | Aug 11, 2026 |
| Q1 2025 Earnings Presentation | Earnings | 10 slides | May 14, 2025 |
| Q4 2024 Earnings Presentation | Earnings | 12 slides | Feb 27, 2025 |
| Q3 2024 Earnings Presentation | Earnings | 13 slides | Oct 31, 2024 |
| Q2 2024 Earnings Presentation | Earnings | 19 slides | Aug 8, 2024 |
| Q1 2024 Earnings Presentation | Earnings | 13 slides | May 2, 2024 |
| Q4 2023 Earnings Presentation | Earnings | 18 slides | Feb 28, 2024 |
| TIDES USA 2024 | Conference | 12 slides | 2024 |
| TIDES EU 2024 | Conference | 21 slides | 2024 |
All 24 decks
| Deck | Kind | Slides | Date |
|---|---|---|---|
| Q3 2023 Earnings Presentation | Earnings | 9 slides | Nov 2, 2023 |
| Q4 2022 Earnings Presentation | Earnings | 18 slides | Feb 23, 2023 |
| Q3 2022 Earnings Presentation | Earnings | 9 slides | Nov 3, 2022 |
| Q2 2022 Earnings Presentation | Earnings | 16 slides | Aug 4, 2022 |
| Q1 2022 Earnings Presentation | Earnings | 12 slides | May 5, 2022 |
| Q4 2021 Earnings Presentation | Earnings | 14 slides | Feb 24, 2022 |
| Q3 2021 Earnings Presentation | Earnings | 10 slides | Nov 4, 2021 |
| Q2 2021 Earnings Presentation | Earnings | 12 slides | Aug 5, 2021 |
| Q1 2021 Earnings Presentation | Earnings | 10 slides | May 6, 2021 |
| Q4 2020 Earnings Presentation | Earnings | 11 slides | Feb 25, 2021 |
| FY2019 Earnings Presentation | Earnings | 10 slides | Feb 27, 2020 |
| Investor Presentation (March 2018) | Investor deck | 33 slides | Mar 12, 2018 |
| Investor Presentation (September 2017) | Investor deck | 23 slides | Sep 8, 2017 |
| Investor Presentation (March 2013) | Investor deck | 11 slides | March 2013 |
Financings
| Raise | Date |
|---|---|
| Public offering of common stock Closed: US$25M raised · US$1.5 a share · Piper Sandler +2 Dealers: Piper Sandler (co-lead), Cantor (co-lead), Craig-Hallum Use of proceeds: Working capital and general corporate purposes, including research, development and business activities | Aug 11, 2026 |
| At-the-market programme of common stock Closed: at-the-market programme Use of proceeds: To advance the ECO Synthesis platform, including a path to GMP-grade siRNA material for customers | Aug 13, 2025 |
Open Financings · Read by 6ix AI from the company's releases
Financials
Annual, in USD
Income statement
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 70.4M | 59.3M | 70.1M | 138.6M | 104.8M | 69.1M | 68.5M | 60.6M | 50.0M | 48.8M |
| Cost of revenue | 9.34M | 16.3M | 12.8M | 38.0M | 22.2M | 13.7M | 15.6M | 12.6M | 14.3M | 9.75M |
| Gross profit | 61.0M | 43.1M | 57.3M | 100.6M | 82.5M | 55.3M | 52.8M | 48.0M | 35.7M | 39.1M |
| Research and development | 52.3M | 46.3M | 58.9M | 80.1M | 55.9M | 44.2M | 33.9M | 30.0M | 29.7M | 22.2M |
| Selling, general and administrative | 47.1M | 55.1M | 53.3M | 52.2M | 49.3M | 35.0M | 31.5M | 29.3M | 29.0M | 25.4M |
| Operating income | -41.7M | -58.5M | -68.1M | -34.9M | -22.7M | -23.9M | -12.5M | -11.3M | -23.0M | -8.56M |
| Depreciation and amortization | 5.25M | 4.95M | 5.52M | 5.40M | 3.11M | 1.95M | 1.57M | 1.15M | 1.04M | 1.73M |
| EBITDA | -36.5M | -53.6M | -62.6M | -29.5M | -19.6M | -22.0M | -11.0M | -10.1M | -21.9M | -6.83M |
| Interest expense | 4.81M | 10.4M | 12.3M | 1.44M | 7.55M | 4.80M | 5.19M | 671.0K | 147.0K | 60.0K |
| Income before tax | -43.9M | -65.2M | -76.2M | -33.3M | -21.1M | -23.7M | -11.9M | -10.9M | -22.9M | -8.60M |
| Income tax | 47.0K | 34.0K | 69.0K | 276.0K | 189.0K | 339.0K | 17.0K | -37.0K | 81.0K | -40.0K |
| Net income | -44.0M | -65.3M | -76.2M | -33.6M | -21.3M | -24.0M | -11.9M | -10.9M | -23.0M | -8.56M |
| Earnings per share, basic | -0.50 | -0.89 | -1.12 | -0.51 | -0.33 | -0.40 | -0.21 | -0.21 | -0.50 | -0.21 |
| Earnings per share, diluted | -0.50 | -0.89 | -1.12 | -0.51 | -0.33 | -0.40 | -0.21 | -0.21 | -0.50 | -0.21 |
Balance sheet
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | 50.8M | 19.3M | 65.1M | 114.0M | 116.8M | 149.1M | 90.5M | 53.0M | 31.2M | 19.2M |
| Short-term investments | 27.4M | 54.2M | 0 | 0 | 1.00M | 0 | 0 | |||
| Receivables | 10.7M | 18.9M | 10.0M | 31.9M | 25.0M | 13.9M | 9.06M | 11.6M | 11.4M | 5.92M |
| Inventory | 1.82M | 1.80M | 2.69M | 2.03M | 1.16M | 964.0K | 371.0K | 589.0K | 1.04M | 825.0K |
| Current assets | 96.8M | 98.8M | 93.5M | 162.9M | 161.9M | 184.4M | 114.2M | 68.2M | 45.0M | 27.2M |
| Property, plant and equipment | 13.0M | 14.2M | 15.5M | 22.6M | 21.3M | 9.68M | 6.28M | 4.76M | 2.81M | 2.15M |
| Goodwill | 2.46M | 2.46M | 2.46M | 3.24M | 3.24M | 3.24M | 3.24M | 3.24M | 3.24M | 3.24M |
| Total assets | 147.8M | 149.0M | 136.6M | 250.4M | 246.4M | 221.6M | 149.1M | 79.3M | 53.6M | 35.6M |
| Accounts payable | 1.55M | 2.84M | 5.95M | 3.25M | 3.00M | 2.97M | 2.62M | 3.05M | 3.54M | 4.23M |
| Current liabilities | 25.3M | 23.6M | 35.8M | 49.1M | 33.4M | 25.0M | 15.4M | 18.1M | 25.0M | 12.4M |
| Long-term debt | 40.1M | 28.9M | 0 | 302.0K | 0 | |||||
| Total debt | 40.1M | 28.9M | 0 | 43.6M | 47.7M | 25.0M | 26.1M | 486.0K | 302.0K | 0 |
| Total liabilities | 97.3M | 82.1M | 49.9M | 105.6M | 82.0M | 51.5M | 43.6M | 23.0M | 29.1M | 16.5M |
| Shareholders' equity | 50.5M | 66.9M | 86.6M | 144.8M | 164.4M | 170.1M | 105.5M | 56.3M | 24.5M | 19.1M |
| Shares outstanding | 90.5M | 81.8M | 69.9M | 65.8M | 65.1M | 64.3M | 58.9M | 54.1M | 48.4M | 41.3M |
Cash flow
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash from operations | -19.4M | -49.4M | -52.6M | 11.3M | -14.3M | -16.5M | -12.6M | -14.1M | -8.76M | -1.86M |
| Capital spending | -4.47M | -4.30M | -4.42M | -8.31M | -13.8M | -3.75M | -3.73M | -2.77M | -985.0K | -888.0K |
| Free cash flow | -23.8M | -53.7M | -57.1M | 2.98M | -28.1M | -20.2M | -16.3M | -16.9M | -9.74M | -2.75M |
| Cash from investing | 23.5M | -57.0M | -4.86M | -13.6M | -21.4M | -5.75M | -3.67M | -2.77M | -983.0K | -846.0K |
| Cash from financing | 27.9M | 60.5M | 8.17M | -575.0K | 3.77M | 80.8M | 54.0M | 38.6M | 21.6M | -490.0K |
| Dividends paid | -1.26M | -2.85M | 0 | 0 | ||||||
| Share buybacks | -404.0K | -1.49M | -1.21M | -1.26M | -2.85M | -3.19M | -1.67M | -1.52M | ||
| Change in cash | 32.1M | -45.9M | -49.3M | -2.87M | -31.9M | 58.6M | 37.7M | 21.7M | 11.9M | -3.20M |
Filings
| Filing | Date | Type | Filed with |
|---|---|---|---|
| 4 · Change in ownership | Nov 18, 2026 | Insider trade | SEC |
| 144 · Notice of proposed sale | Nov 16, 2026 | Other filings | SEC |
| SCHEDULE 13G/A · Big-stake notice, amended | Nov 16, 2026 | Big-stake notice | SEC |
| 10-Q · Quarterly report | Nov 12, 2026 | Quarterly report | SEC |
| 8-K · Current report | Nov 12, 2026 | Results | SEC |
| 4 · Change in ownership | Nov 10, 2026 | Insider trade | SEC |
| 8-K · Current report | Nov 10, 2026 | Material contract | SEC |
| SCHEDULE 13G/A · Big-stake notice, amended | Nov 6, 2026 | Big-stake notice | SEC |
| SCHEDULE 13G/A · Big-stake notice, amended | Oct 30, 2026 | Big-stake notice | SEC |
| 4 · Change in ownership | Oct 14, 2026 | Insider trade | SEC |
Show 200 filings
| Filing | Date | Type | Filed with |
|---|---|---|---|
| 4 · Change in ownership | Oct 14, 2026 | Insider trade | SEC |
| 144 · Notice of proposed sale | Oct 13, 2026 | Other filings | SEC |
| 144 · Notice of proposed sale | Oct 13, 2026 | Other filings | SEC |
| SCHEDULE 13G/A · Big-stake notice, amended | Aug 13, 2026 | Big-stake notice | SEC |
| 10-Q · Quarterly report | Aug 11, 2026 | Quarterly report | SEC |
| 8-K · Current report | Aug 11, 2026 | Results | SEC |
| SCHEDULE 13G · Big-stake notice | Jul 29, 2026 | Big-stake notice | SEC |
| 8-K · Current report | Jul 27, 2026 | Current report | SEC |
| 424B5 · Prospectus | Jul 24, 2026 | Offer document | SEC |
| 424B5 · Prospectus | Jul 23, 2026 | Offer document | SEC |
| 8-K · Current report | Jul 23, 2026 | Results | SEC |
| SCHEDULE 13G/A · Big-stake notice, amended | Jul 20, 2026 | Big-stake notice | SEC |
| 8-K · Current report | Jun 22, 2026 | Meeting outcome | SEC |
| 4 · Change in ownership | Jun 18, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Jun 18, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Jun 18, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Jun 18, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Jun 18, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Jun 18, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Jun 18, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Jun 18, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Jun 11, 2026 | Insider trade | SEC |
| 10-Q · Quarterly report | May 7, 2026 | Quarterly report | SEC |
| 8-K · Current report | May 7, 2026 | Results | SEC |
| SCHEDULE 13G/A · Big-stake notice, amended | May 5, 2026 | Big-stake notice | SEC |
| ARS · Annual report to shareholders | Apr 28, 2026 | Annual report | SEC |
| DEFA14A · Additional proxy material | Apr 28, 2026 | Meeting notice | SEC |
| DEF 14A · Proxy statement | Apr 28, 2026 | Meeting notice | SEC |
| SCHEDULE 13G · Big-stake notice | Apr 14, 2026 | Big-stake notice | SEC |
| 8-K · Current report | Apr 14, 2026 | Management or board change | SEC |
| SCHEDULE 13G/A · Big-stake notice, amended | Mar 26, 2026 | Big-stake notice | SEC |
| 10-K · Annual report | Mar 11, 2026 | Annual report | SEC |
| 8-K · Current report | Mar 11, 2026 | Results | SEC |
| SCHEDULE 13G · Big-stake notice | Mar 11, 2026 | Big-stake notice | SEC |
| 4 · Change in ownership | Feb 25, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Feb 25, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Feb 25, 2026 | Insider trade | SEC |
| 144 · Notice of proposed sale | Feb 23, 2026 | Other filings | SEC |
| 4 · Change in ownership | Feb 9, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Feb 9, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Feb 9, 2026 | Insider trade | SEC |
| 144 · Notice of proposed sale | Feb 6, 2026 | Other filings | SEC |
| 144 · Notice of proposed sale | Feb 6, 2026 | Other filings | SEC |
| SCHEDULE 13G/A · Big-stake notice, amended | Jan 23, 2026 | Big-stake notice | SEC |
| 144 · Notice of proposed sale | Jan 16, 2026 | Other filings | SEC |
| SCHEDULE 13G/A · Big-stake notice, amended | Jan 15, 2026 | Big-stake notice | SEC |
| 4 · Change in ownership | Jan 8, 2026 | Insider trade | SEC |
| 144 · Notice of proposed sale | Jan 7, 2026 | Other filings | SEC |
| 4/A · Change in ownership, amended | Dec 15, 2025 | Insider trade | SEC |
| 4/A · Change in ownership, amended | Dec 15, 2025 | Insider trade | SEC |
| SCHEDULE 13G/A · Big-stake notice, amended | Dec 5, 2025 | Big-stake notice | SEC |
| 4 · Change in ownership | Dec 1, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Nov 25, 2025 | Insider trade | SEC |
| 144 · Notice of proposed sale | Nov 21, 2025 | Other filings | SEC |
| 4 · Change in ownership | Nov 17, 2025 | Insider trade | SEC |
| 3 · Initial statement of ownership | Nov 17, 2025 | Insider trade | SEC |
| SCHEDULE 13G/A · Big-stake notice, amended | Nov 14, 2025 | Big-stake notice | SEC |
| 4 · Change in ownership | Nov 14, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Nov 13, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Nov 12, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Nov 12, 2025 | Insider trade | SEC |
| SCHEDULE 13G/A · Big-stake notice, amended | Nov 7, 2025 | Big-stake notice | SEC |
| 10-Q · Quarterly report | Nov 6, 2025 | Quarterly report | SEC |
| 8-K · Current report | Nov 6, 2025 | Results | SEC |
| SCHEDULE 13G/A · Big-stake notice, amended | Nov 5, 2025 | Big-stake notice | SEC |
| 4 · Change in ownership | Oct 15, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Oct 15, 2025 | Insider trade | SEC |
| 144 · Notice of proposed sale | Oct 14, 2025 | Other filings | SEC |
| 144 · Notice of proposed sale | Oct 14, 2025 | Other filings | SEC |
| SCHEDULE 13G/A · Big-stake notice, amended | Aug 14, 2025 | Big-stake notice | SEC |
| S-8 · Registration statement for employee plans | Aug 13, 2025 | Offer document | SEC |
| 10-Q · Quarterly report | Aug 13, 2025 | Quarterly report | SEC |
| 8-K · Current report | Aug 13, 2025 | Results | SEC |
| 4 · Change in ownership | Aug 4, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Jul 31, 2025 | Insider trade | SEC |
| SCHEDULE 13G · Big-stake notice | Jul 30, 2025 | Big-stake notice | SEC |
| 4 · Change in ownership | Jul 22, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Jul 1, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Jun 16, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Jun 12, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Jun 12, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Jun 12, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Jun 12, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Jun 12, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Jun 12, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Jun 12, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Jun 12, 2025 | Insider trade | SEC |
| 8-K · Current report | Jun 11, 2025 | Management or board change | SEC |
| 4 · Change in ownership | May 28, 2025 | Insider trade | SEC |
| 10-Q · Quarterly report | May 14, 2025 | Quarterly report | SEC |
| 8-K · Current report | May 14, 2025 | Results | SEC |
| 4 · Change in ownership | May 2, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Apr 29, 2025 | Insider trade | SEC |
| DEFA14A · Additional proxy material | Apr 24, 2025 | Meeting notice | SEC |
| DEF 14A · Proxy statement | Apr 24, 2025 | Meeting notice | SEC |
| SCHEDULE 13G/A · Big-stake notice, amended | Apr 24, 2025 | Big-stake notice | SEC |
| 4 · Change in ownership | Apr 17, 2025 | Insider trade | SEC |
| 8-K · Current report | Apr 9, 2025 | Management or board change | SEC |
| 4 · Change in ownership | Apr 9, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Apr 3, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Apr 1, 2025 | Insider trade | SEC |
| 3 · Initial statement of ownership | Apr 1, 2025 | Insider trade | SEC |
| 8-K · Current report | Mar 31, 2025 | Management or board change | SEC |
| 4 · Change in ownership | Mar 24, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Mar 14, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Mar 10, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Mar 6, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Mar 4, 2025 | Insider trade | SEC |
| 10-K · Annual report | Feb 27, 2025 | Annual report | SEC |
| 8-K · Current report | Feb 27, 2025 | Results | SEC |
| 4 · Change in ownership | Feb 12, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Feb 7, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Feb 7, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Feb 7, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Feb 7, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Jan 31, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Jan 16, 2025 | Insider trade | SEC |
| 3 · Initial statement of ownership | Jan 16, 2025 | Insider trade | SEC |
| 8-K · Current report | Jan 16, 2025 | Management or board change | SEC |
| 4 · Change in ownership | Jan 2, 2025 | Insider trade | SEC |
| SCHEDULE 13G/A · Big-stake notice, amended | Nov 14, 2024 | Big-stake notice | SEC |
| 4 · Change in ownership | Nov 12, 2024 | Insider trade | SEC |
| 3 · Initial statement of ownership | Nov 12, 2024 | Insider trade | SEC |
| 8-K · Current report | Nov 12, 2024 | Management or board change | SEC |
| 10-Q · Quarterly report | Oct 31, 2024 | Quarterly report | SEC |
| 8-K · Current report | Oct 31, 2024 | Results | SEC |
| 4 · Change in ownership | Oct 28, 2024 | Insider trade | SEC |
| 8-K · Current report | Oct 22, 2024 | Management or board change | SEC |
| 4 · Change in ownership | Oct 10, 2024 | Insider trade | SEC |
| 4 · Change in ownership | Oct 10, 2024 | Insider trade | SEC |
| 3 · Initial statement of ownership | Oct 10, 2024 | Insider trade | SEC |
| 8-K · Current report | Oct 2, 2024 | Management or board change | SEC |
| 4 · Change in ownership | Sep 26, 2024 | Insider trade | SEC |
| SC 13G · Big-stake notice | Sep 26, 2024 | Big-stake notice | SEC |
| 4 · Change in ownership | Sep 23, 2024 | Insider trade | SEC |
| 4 · Change in ownership | Sep 19, 2024 | Insider trade | SEC |
| SC 13G/A · Big-stake notice, amended | Sep 18, 2024 | Big-stake notice | SEC |
| S-8 · Registration statement for employee plans | Aug 9, 2024 | Offer document | SEC |
| 10-Q · Quarterly report | Aug 8, 2024 | Quarterly report | SEC |
| 8-K · Current report | Aug 8, 2024 | Results | SEC |
| SC 13G · Big-stake notice | Jul 12, 2024 | Big-stake notice | SEC |
| 4 · Change in ownership | Jun 13, 2024 | Insider trade | SEC |
| 4 · Change in ownership | Jun 13, 2024 | Insider trade | SEC |
| 4 · Change in ownership | Jun 13, 2024 | Insider trade | SEC |
| 4 · Change in ownership | Jun 13, 2024 | Insider trade | SEC |
| 4 · Change in ownership | Jun 13, 2024 | Insider trade | SEC |
| 4 · Change in ownership | Jun 13, 2024 | Insider trade | SEC |
| 4 · Change in ownership | Jun 13, 2024 | Insider trade | SEC |
| 8-K · Current report | Jun 13, 2024 | Meeting outcome | SEC |
| EFFECT · Notice that a registration is effective | May 15, 2024 | Other filings | SEC |
| 424B5 · Prospectus | May 14, 2024 | Offer document | SEC |
| 8-K · Current report | May 14, 2024 | Current report | SEC |
| CORRESP · Letter to the SEC | May 10, 2024 | Other filings | SEC |
| UPLOAD · Letter from the SEC | May 10, 2024 | Other filings | SEC |
| S-3 · Registration statement | May 2, 2024 | Offer document | SEC |
| 10-Q · Quarterly report | May 2, 2024 | Quarterly report | SEC |
| 8-K · Current report | May 2, 2024 | Results | SEC |
| DEFA14A · Additional proxy material | Apr 25, 2024 | Meeting notice | SEC |
| DEF 14A · Proxy statement | Apr 25, 2024 | Meeting notice | SEC |
| 8-K · Current report | Mar 6, 2024 | Current report | SEC |
| 10-K · Annual report | Feb 28, 2024 | Annual report | SEC |
| 8-K · Current report | Feb 28, 2024 | Results | SEC |
| 8-K · Current report | Feb 16, 2024 | Management or board change | SEC |
| SC 13G/A · Big-stake notice, amended | Feb 14, 2024 | Big-stake notice | SEC |
| SC 13G/A · Big-stake notice, amended | Feb 13, 2024 | Big-stake notice | SEC |
| 8-K · Current report | Feb 13, 2024 | Material contract | SEC |
| 8-K · Current report | Feb 9, 2024 | Current report | SEC |
| SC 13G · Big-stake notice | Feb 9, 2024 | Big-stake notice | SEC |
| SC 13G/A · Big-stake notice, amended | Jan 24, 2024 | Big-stake notice | SEC |
| 8-K · Current report | Jan 9, 2024 | Results | SEC |
| SC 13G/A · Big-stake notice, amended | Jan 8, 2024 | Big-stake notice | SEC |
| 4 · Change in ownership | Jan 2, 2024 | Insider trade | SEC |
| 4 · Change in ownership | Jan 2, 2024 | Insider trade | SEC |
| 4 · Change in ownership | Jan 2, 2024 | Insider trade | SEC |
| 4 · Change in ownership | Jan 2, 2024 | Insider trade | SEC |
| 8-K · Current report | Dec 27, 2023 | Material contract | SEC |
| 4 · Change in ownership | Nov 17, 2023 | Insider trade | SEC |
| 144 · Notice of proposed sale | Nov 15, 2023 | Other filings | SEC |
| 4 · Change in ownership | Nov 14, 2023 | Insider trade | SEC |
| 8-K/A · Current report, amended | Nov 3, 2023 | Current report | SEC |
| 10-Q · Quarterly report | Nov 3, 2023 | Quarterly report | SEC |
| 8-K · Current report | Nov 2, 2023 | Results | SEC |
| 8-K · Current report | Sep 22, 2023 | Current report | SEC |
| 4 · Change in ownership | Sep 12, 2023 | Insider trade | SEC |
| 4 · Change in ownership | Sep 12, 2023 | Insider trade | SEC |
| 4 · Change in ownership | Sep 12, 2023 | Insider trade | SEC |
| 4 · Change in ownership | Sep 12, 2023 | Insider trade | SEC |
| 8-K · Current report | Sep 7, 2023 | Material contract | SEC |
| SC 13G/A · Big-stake notice, amended | Aug 8, 2023 | Big-stake notice | SEC |
| S-8 · Registration statement for employee plans | Aug 3, 2023 | Offer document | SEC |
This page holds 200 of 1,000 filings. Open Filings
Cap table
Built by 6ix from Codexis, Inc.’s releases · as of Nov 9, 2026
- Common shares
- 109,597,529
- Fully diluted
- 109,597,529
Fully diluted
| Line | Shares | As of |
|---|---|---|
| Common shares | 109,597,529 | Nov 9, 2026 |
Share count over time
| Count | Shares |
|---|---|
| Nov 9, 2026 | 109,597,529 |
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| James R Sulat Other companies: Mallinckrodt Inc (Director · Jun 16, 2022 – Nov 14, 2023 · Past); Exicure, Inc. (Director · Jan 2, 2021 – Jun 13, 2022 · Past); Arch Therapeutics Inc (Director · Aug 19, 2015 – Sep 27, 2021 · Past); AMAG Pharmaceuticals Inc (Director · Apr 14, 2014 – Nov 16, 2020 · Past); Momenta Pharmaceuticals Inc (Director · Jun 5, 2008 – Jun 19, 2019 · Past); Memory Pharmaceuticals Corp (Director · Jun 5, 2006 – Jan 1, 2009 · Past); Maxygen Inc (Former CEO & CFO, Director · May 30, 2006 – Jun 30, 2013 · Past) | Director · Apr 21, 2010 – Apr 27, 2010 · Past |
| Jennifer Aaker Other companies: Agriculture & Natural Solutions Acquisition Corporation (Director · Nov 8, 2023 – Nov 8, 2023 · Past); Decarbonization Plus Acquisition Corporation IV (Director · Aug 10, 2021 – Feb 22, 2023 · Past); Solid Power, Inc. (Director · Mar 23, 2021 – Dec 8, 2021 · Past); Decarbonization Plus Acquisition Corporation II (Director · Feb 3, 2021 – Jan 13, 2022 · Past); Decarbonization Plus Acquisition Corporation (Director · Oct 20, 2020 – Oct 20, 2020 · Past) | Director · Jun 15, 2021 – Jun 13, 2023 · Past |
| Patrick Yang Other companies: Sana Biotechnology, Inc. (Director · Since at least Feb 3, 2021); Amyris Inc (Director · Jul 1, 2014 – Aug 5, 2020 · Past); Eiger Biopharmaceuticals Inc (Director · Mar 2, 2014 – May 20, 2014 · Past); Andeavor (Director · Dec 8, 2010 – Oct 1, 2018 · Past); Genentech Inc (EVP, Product Operations · Mar 26, 2009 – Mar 26, 2009 · Past) | Director · Feb 22, 2014 – Jun 14, 2022 · Past |
| H Stewart Parker Other companies: Sangamo Therapeutics, Inc. (Director · Since at least Jun 17, 2014); Impel Neuropharma Inc (Director · Apr 22, 2021 – Jul 11, 2021 · Past); Achieve Life Sciences, Inc. (Director · Mar 23, 2010 – May 12, 2020 · Past); Armata Pharmaceuticals, Inc. (Director · Jun 12, 2006 – May 22, 2019 · Past) | Director · Since at least Dec 16, 2022 |
| Stephen George Dilly Other companies: Sierra Oncology Inc (CEO and President, Director · Jun 1, 2020 – Jul 1, 2022 · Past); Aimmune Therapeutics Inc (President and CEO, Director · Aug 5, 2015 – Jun 11, 2018 · Past); Sangamo Therapeutics, Inc. (Director · Jun 12, 2013 – May 18, 2020 · Past) | Director · Since at least Jun 16, 2020 |
| Cynthia Collins Other companies: MaxCyte, Inc. (Director · Since at least Jun 18, 2025); Certara, Inc. (Director · Since at least May 21, 2025) | Director · Since at least Mar 28, 2025 |
| Gordon Sangster Other companies: Micrus Endovascular Corp (Chief Financial Officer · Nov 12, 2007 – Sep 27, 2010 · Past); Hemosense Inc (Chief Financial Officer · Sep 18, 2006 – Nov 6, 2007 · Past) | SVP & Chief Financial Officer · Aug 18, 2014 – Mar 20, 2019 · Past |
| Kevin Norrett Other companies: Soleno Therapeutics, Inc. (Chief Business Officer · Since at least Nov 17, 2025); Sierra Oncology Inc (Chief Business Officer · Aug 10, 2020 – Jul 1, 2022 · Past) | Chief Operating Officer · Oct 3, 2022 – Feb 5, 2025 · Past |
| Sriram Ryali Other companies: Caribou Biosciences, Inc. (Chief Financial Officer · Since at least Jan 2, 2025); Eiger Biopharmaceuticals Inc (Chief Financial Officer · Dec 17, 2018 – Mar 14, 2022 · Past) | Chief Financial Officer · Jan 23, 2023 – Jan 1, 2024 · Past |
| Alison Moore Other companies: Artiva Biotherapeutics, Inc. (Director · Since at least Jun 24, 2025) | President and CEO, Director · Since at least Oct 13, 2025 |
All 28 people
| Person | Seat |
|---|---|
| Christos Richards Other companies: Coherus Oncology, Inc. (Director · Nov 6, 2014 – Jan 10, 2020 · Past) | Director · Since at least Jan 14, 2025 |
| Georgia Erbez Other companies: Coherus Oncology, Inc. (Director · Since at least Jun 12, 2025) | See Remarks · Since at least Oct 13, 2025 |
| Jim Lalonde Other companies: eXoZymes Inc. (Board Member, Formerly SVP of R&D Codexis · Since at least Apr 21, 2025) | SVP, R&D · Feb 5, 2014 – May 13, 2019 · Past |
| Kathleen Sereda Glaub Other companies: Aligos Therapeutics, Inc. (Director · Oct 15, 2020 – Oct 15, 2020 · Past) | Director · Jun 11, 2019 – Jun 11, 2019 · Past |
| Margaret Nell Fitzgerald Other companies: Allakos Inc (General Counsel and Secretary · Apr 19, 2022 – Sep 2, 2022 · Past) | See Remarks · Oct 31, 2022 – Jan 1, 2024 · Past |
| Rahul Singhvi Other companies: Kairos Pharma, Ltd. (Director · Since at least Dec 10, 2024) | Director · Since at least Sep 28, 2022 |
| Amy Westfall | Senior Vice President, Strategy and Program Management · Since at least Nov 5, 2026 |
| Bernard J Kelley | Director · Apr 21, 2010 – Aug 10, 2021 · Past |
| Britton Jimenez | Senior Vice President, Sales and Marketing · Since at least Nov 5, 2026 |
| David L Anton | SVP, BioIndustrials · Apr 21, 2010 – Feb 10, 2013 · Past |
| Dennis P Wolf | Director · Since at least Jun 11, 2024 |
| Esther Martinborough | Director · Since at least Feb 2, 2021 |
| Karen Frechou-Armijo | Senior Vice President, Head of Human Resources · Since at least Nov 5, 2026 |
| Mark Ho | Principal Accounting Officer · Jul 10, 2012 – Jul 10, 2012 · Past |
| Matthew Tobin | SVP, Research & Development · Aug 28, 2012 – May 16, 2013 · Past |
| Mun Yew Wong | Director · Apr 21, 2010 – Apr 27, 2010 · Past |
| Raymond De Vre | Director · Since at least Nov 7, 2024 |
| Stefan Lutz | Chief Scientific Officer · Since at least May 20, 2026 |
Log in to ask 6ix AI your own questions about Codexis, Inc.